Antitumor Activity of ME2303, a Fluorine‐containing Anthracycline, against Human Tumors Implanted in Nude Mice

A fluorine‐containing anthracyctine, ME2303, given intravenously once a week for 4 weeks at the maximum tolerated dose showed better therapeutic effects against 2 gastric, 3 lung and 2 human breast tumor xenografts than did adriamycin (ADM) at the maximum tolerated dose. Among the tumors, ME2303 sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuruo, Takashi, Sato, Shigeo, Yusa, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1989
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917819/
https://www.ncbi.nlm.nih.gov/pubmed/2507492
http://dx.doi.org/10.1111/j.1349-7006.1989.tb01697.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917819/
https://www.ncbi.nlm.nih.gov/pubmed/2507492
http://dx.doi.org/10.1111/j.1349-7006.1989.tb01697.x

Ejemplares similares